Who to call at YD Bio Limited, and when
Fundz watches for the moments YD Bio Limited starts buying, and tells you who to reach.
- An alert the day YD Bio Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at YD Bio Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at YD Bio Limited. With Fundz connected, it knows.
YD Bio and EG BioMed Form Partnership with JoiiUp to Launch AI Cancer Risk Assessment for Corporate Wellness.
Contract Type
partnership
IrvingBiotechnologyHealth CareMedicalTherapeuticsBiopharmaDescription
YD Bio Limited has announced a strategic partnership with EG BioMed and JoiiUp to launch an AI-driven Cancer Risk Assessment. This initiative integrates a personalized health tool into JoiiUp's app, improving access to health insights for corporate wellness programs.
Quick answer
YD Bio and EG BioMed Form Partnership with JoiiUp to Launch AI Cancer Risk Assessment for Corporate Wellness. (October 20, 2026). YD Bio Limited is based in Irving, Texas, United States.
- What agreement did YD Bio Limited announce on October 20, 2026?
- YD Bio Limited has announced a strategic partnership with EG BioMed and JoiiUp to launch an AI-driven Cancer Risk Assessment. This initiative integrates a personalized health tool into JoiiUp's app, improving access to health insights for corporate wellness programs.
- What does YD Bio Limited do?
- YD Bio Limited is a biotechnology company focused on advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
- Where is YD Bio Limited based?
- YD Bio Limited is based in Irving, Texas, United States.
- Which similar companies announced agreements around the same time?
- Georgiamune (October 25, 2026), Cognito Therapeutics (October 27, 2026), BioMarin Pharmaceutical (October 29, 2026) and Alexion (October 29, 2026) also announced agreements within 45 days of YD Bio Limited.
Source: Fundz verified event record.
Other recent agreements in Medical and Therapeutics
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Menarini and Georgiamune Enter $1.1 Billion License Agreement for Cancer Immunotherapy GIM-621. (October 25, 2026)
- Rhode Island Life Science Hub and Cognito Therapeutics launch partnership for Alzheimer's research. (October 27, 2026)
- BioMarin Enters Exclusive License Agreement With GC Biopharma and Hanmi Pharm for HM15421/GC1134A to Treat Fabry Disease. (October 29, 2026)
- Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- DARPA Awards Up to $10.7 Million Contract to RxMP Therapeutics for Development of RMP-402. (October 20, 2026)
Agreement Insights
What this usually meansYD Bio Limited signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.